Keywords
How to Cite
Abstract
Chronic Heart Failure (CHF) is a complex clinical syndrome resulting from structural or functional impairment of ventricular filling or ejection of blood. It represents a leading cause of hospitalization and mortality worldwide. CHF is characterized by neurohormonal activation, reduced cardiac output, and systemic congestion. This paper examines the epidemiology, pathophysiology, classification, clinical presentation, diagnostic strategies, complications, and modern treatment approaches of chronic heart failure following the IMRAD structure.
References
1. McDonagh TA, et al. (2021). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal.
2. Heidenreich PA, et al. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Circulation.
3. Packer M, et al. (2020). Cardiovascular and renal outcomes with empagliflozin in heart failure. New England Journal of Medicine.
4. SOLVD Investigators. (1991). Effect of enalapril on survival in heart failure. NEJM.
5. PARADIGM-HF Investigators. (2014). LCZ696 versus enalapril in heart failure. NEJM.
6. Braunwald E. (2015). Heart failure. The Lancet.
7. Yancy CW, et al. (2017). ACC/AHA Heart Failure Guidelines. Circulation.